Variant report
Variant | esv3459021 |
---|---|
Chromosome Location | chr2:206127897-206129976 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs143645840 | chr2:206127915-206127916 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187426840 | chr2:206127938-206127939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549279929 | chr2:206127990-206127991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567762093 | chr2:206128018-206128019 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35550134 | chr2:206128040-206128041 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534764558 | chr2:206128116-206128117 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115146252 | chr2:206128162-206128163 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6753078 | chr2:206128178-206128179 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs532632375 | chr2:206128225-206128226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs11901919 | chr2:206128232-206128233 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs114650334 | chr2:206128270-206128271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139485219 | chr2:206128303-206128304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564246331 | chr2:206128315-206128316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548950905 | chr2:206128355-206128356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs77015672 | chr2:206128407-206128408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191798738 | chr2:206128461-206128462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572896484 | chr2:206128472-206128473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34794425 | chr2:206128548-206128549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530015694 | chr2:206128573-206128574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539984493 | chr2:206128607-206128608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558219891 | chr2:206128682-206128683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112477054 | chr2:206128720-206128721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543781650 | chr2:206128733-206128734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563658493 | chr2:206128758-206128759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531073783 | chr2:206128835-206128836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145048672 | chr2:206128839-206128840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543211595 | chr2:206128857-206128858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537870559 | chr2:206128912-206128913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370849349 | chr2:206128936-206128937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528678809 | chr2:206129023-206129024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547152560 | chr2:206129070-206129071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs372055763 | chr2:206129080-206129081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs144291582 | chr2:206129205-206129206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182931728 | chr2:206129223-206129224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548867000 | chr2:206129250-206129251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116672762 | chr2:206129259-206129260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569142197 | chr2:206129303-206129304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536110461 | chr2:206129304-206129305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554844782 | chr2:206129460-206129461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552434136 | chr2:206129585-206129586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs147385995 | chr2:206129594-206129595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186536394 | chr2:206129600-206129601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534450402 | chr2:206129603-206129604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35271060 | chr2:206129622-206129623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558256723 | chr2:206129642-206129643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113520113 | chr2:206129644-206129645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139581832 | chr2:206129646-206129647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs558051664 | chr2:206129672-206129673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543817822 | chr2:206129697-206129698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555843032 | chr2:206129711-206129712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Cervical cancer | 21062161 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 16573809 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cancer | 20164920 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:206097200-206170600 | Weak transcription | HSMMtube | muscle |
2 | chr2:206108400-206145200 | Weak transcription | HSMM | muscle |
3 | chr2:206113400-206139800 | Weak transcription | Pancreas | Pancrea |
4 | chr2:206118200-206156600 | Weak transcription | Aorta | Aorta |
5 | chr2:206127400-206128000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
6 | chr2:206127800-206128200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr2:206128000-206128200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr2:206128000-206128200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr2:206128200-206130600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
10 | chr2:206128200-206131000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
11 | chr2:206128400-206130000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |